Testimony before the FDA’s Bone, Reproductive and Urologic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee Regarding Testosterone Products

View the Presentation as a PDF.

View the Testimony as a PDF.

View the Press Release.

Public Citizen urges the Food and Drug Administration (FDA) to require that the product labels of all testosterone-containing medications available in the U.S. be revised to include warnings about the increased risk of heart attacks and other life-threatening cardiovascular dangers.